Cost saving in primary versus tertiary level of reproductive health services in Sana’a, Yemen

Abdulkareem Ali Hussein Nassar; Yahia Ahmed Raja’a; Najia Saleh Bahubaishi

doi:10.1101/2021.08.25.21262373

Abstract

Introduction In Yemen, women tend to bypass the nearby primary health level facilities (PHLF) for using vaginal delivery (VD), antenatal care (ANC) and intrauterine device (IUD) services. This study aimed to estimate the cost saving for utilization of VD, ANC and IUD services at PHLF instead of tertiary health level facilities (THLF) in Sana’a.

Methods A comparative cross sectional study design was conducted in 2013. It was used to estimate the costs from the patient’s perspective. A structured questionnaire was used to collect data. Descriptive analyses were performed. P value <0.05 was considered as the cut point for significance. The SPSS version 17 was used.

Results A total of 180 women were found. The median of DMC of VD, ANC and IUD services were US$43.9, US$14.8 and US$9.1 at THLF compared with US$19.5, US$0.9 and US$11.2 at PHLF, respectively. The DMC difference of VD, ANC and IUD services between THLF and PHLF was US$24.4, US$13.9 and US$-2.1, respectively. Regarding the DNMC, the median of VD, ANC and IUD services were US$43.1, US$19.1 and US$17.3 at THLF compared with US$14.0, US$0.0 and US$0.0 at PHLF, respectively. The DNMC difference of VD, ANC and IUD service between THLF and PHLF was US$29.1, US$19.1 and US$17.3, respectively. Moreover, the median of INDC for VD, ANC and IUD services were US$23.9, US$9.5 and US$10.4 at THLF compared with US$7.9, US$1.6 and US$1.1 at PHLF, respectively. The INDC difference of VD, ANC and IUD service between THLF and PHLF was US$16.0, US$7.9 and US$9.3.

Conclusion The study found the utilization of VD, ANC and IUD services at PHLF instead of THLF is a considerable cost saving for families. Therefore, shifting the utilization of services from THLF to PHLF reduces the financial burden affecting individuals, families and their productivity. Implementation of the health referral system is recommended.

What is already known?

➢ Women tend remarkably to bypass the nearby primary reproductive health services that are rising the expenses and increasing the burden borne by individuals, families and their productivity.
➢ Few studies have estimated the cost saving for utilization of primary instead tertiary level of reproductive health services in the world, while no such study was conducted in Yemen.

What are the new findings?

➢ A significant difference in the expenses on reproductive health services between the primary and tertiary health level facilities.
➢ A significant cost is saved for women and families as a result of utilization of primary instead tertiary level of reproductive health services.

What do the new findings imply?

➢ The primary health level facilities reduce the financial burden affecting individuals, families and their productivity.
➢ This study provides evidence for decision-makers to implement the health referral system and protect the families from incurring the high expenditure.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

MS ID#: MEDRXIV/2021/262373

Funding Statement

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted and submitted for the partial fulfillment of the requirements for the degree of Master. It was approved by the Research and Ethics Committee of the Faculty of Medicine and Health Science, Sanaa University. Official letters to conduct this study were sent to The Public Health and Population Offices and the targeted facilities in Sanaa city and governorate. Methods were performed in accordance with the Declaration of Helsinki. Informed consent was taken from all participants. Confidentiality of data was assured and ensured.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes